Ilkka Julkunen
ilkka.julkunen@utu.fi +358 29 450 4507 +358 50 449 9721 Kiinamyllynkatu 10 Turku |
2 of 6
- SytokiinitSerological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood2024Patologia Julkunen, Ilkka
- The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base (2024)
- Cell Discovery
- Virusinfektioiden immunologia (2024) Mikrobiologia, immunologia ja infektiosairaudet. Kirja 2, Immunologia Julkunen, Ilkka; Arstila, Petteri; Silvennoinen, Olli
- Virus-specific Dicer-substrate siRNA swarms inhibit SARS-CoV-2 infection in TMPRSS2-expressing Vero E6 cells (2024)
- Frontiers in microbiology
- Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workersLow pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study (2023)
- Scientific ReportsInfectious Diseases
- COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs (2023)
- Vaccine
- Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection (2023)
- Cell reports : methodsOpen Forum Infectious Diseases
- Infectious viruses from transfected SARS-CoV-2 genomic RNA (2023)
- Frontiers in Bioengineering and Biotechnology
- Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses (2023)
- Biomolecules
- Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose (2023)
- Frontiers in immunology
- T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up (2023)
- Frontiers in immunology
- VP24 matrix proteins of eight filoviruses downregulate innate immune response by inhibiting the interferon-induced pathway (2023)
- Journal of General Virology
- Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants (2022)
- Nature Communications
- Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation (2022)
- Frontiers in immunology
- Inactivation efficacy of H5N1 avian influenza virus by commonly used sample preparation reagents for safe laboratory practices (2022)
- Journal of Virological Methods
- Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients (2022)
- Frontiers in immunology
- (2022)
- SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant (2022)
- Frontiers in immunology
- (2022)
- Microbiology spectrum
- 2022
UTU Research Portal